Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model

Objectives: To compare the TLR2 expression in the placenta between treated by sambiloto EA-96 fraction tablet (AS201-01) and dihydroartemisinin-piperaquine phosphate (DHP) Materials and Methods: Experimental study using 24 pregnant mice. All sample divided into 4 groups with randomization are uni...

Full description

Saved in:
Bibliographic Details
Main Authors: Masyitah Hamidah, -, Aty Widyawaruyanti, -, Widjiati, -, Budi Prasetyo, Budi
Format: Article PeerReviewed
Language:English
Indonesian
English
Published: Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Airlangga
Subjects:
Online Access:https://repository.unair.ac.id/127227/1/1.%20Sambiloto%20AS%2020I-0I.pdf
https://repository.unair.ac.id/127227/2/1.pdf
https://repository.unair.ac.id/127227/3/1.%20Sambiloto%20AS%2020I-0I.pdf
https://repository.unair.ac.id/127227/
https://e-journal.unair.ac.id/MOG/article/view/9449
https://doi.org/10.20473/mog.V26I22018.74-82
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
Indonesian
English
id id-langga.127227
record_format dspace
spelling id-langga.1272272023-06-12T11:32:56Z https://repository.unair.ac.id/127227/ Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model Masyitah Hamidah, - Aty Widyawaruyanti, - Widjiati, - Budi Prasetyo, Budi R5-920 Medicine (General) Objectives: To compare the TLR2 expression in the placenta between treated by sambiloto EA-96 fraction tablet (AS201-01) and dihydroartemisinin-piperaquine phosphate (DHP) Materials and Methods: Experimental study using 24 pregnant mice. All sample divided into 4 groups with randomization are uninfected group, Plasmodium infected group and given placebo, sambiloto (AS201-01) and DHP. Then performed surgery and placental sampling were staining with adopting in tunnel assay method to measure the TLR2 expression of placental. Results: The expression of TLR2 in uninfected group has the lowest rate compared to other groups. The infected and placebo treated group has the highest TLR2 expression campared with sambiloto and DHP. The sambiloto group has not differ signi-ficantly with the group uninfected and lower than DHP. Conclusion: Tablet of sambiloto EA-96 fraction (AS201-01) decreased TLR2 expession better than with DHP tablet. Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Airlangga Article PeerReviewed text en https://repository.unair.ac.id/127227/1/1.%20Sambiloto%20AS%2020I-0I.pdf text id https://repository.unair.ac.id/127227/2/1.pdf text en https://repository.unair.ac.id/127227/3/1.%20Sambiloto%20AS%2020I-0I.pdf Masyitah Hamidah, - and Aty Widyawaruyanti, - and Widjiati, - and Budi Prasetyo, Budi Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model. Majalah Obstetri dan Ginekologi, 26 (12). pp. 74-86. ISSN 2598-1013 https://e-journal.unair.ac.id/MOG/article/view/9449 https://doi.org/10.20473/mog.V26I22018.74-82
institution Universitas Airlangga
building Universitas Airlangga Library
continent Asia
country Indonesia
Indonesia
content_provider Universitas Airlangga Library
collection UNAIR Repository
language English
Indonesian
English
topic R5-920 Medicine (General)
spellingShingle R5-920 Medicine (General)
Masyitah Hamidah, -
Aty Widyawaruyanti, -
Widjiati, -
Budi Prasetyo, Budi
Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model
description Objectives: To compare the TLR2 expression in the placenta between treated by sambiloto EA-96 fraction tablet (AS201-01) and dihydroartemisinin-piperaquine phosphate (DHP) Materials and Methods: Experimental study using 24 pregnant mice. All sample divided into 4 groups with randomization are uninfected group, Plasmodium infected group and given placebo, sambiloto (AS201-01) and DHP. Then performed surgery and placental sampling were staining with adopting in tunnel assay method to measure the TLR2 expression of placental. Results: The expression of TLR2 in uninfected group has the lowest rate compared to other groups. The infected and placebo treated group has the highest TLR2 expression campared with sambiloto and DHP. The sambiloto group has not differ signi-ficantly with the group uninfected and lower than DHP. Conclusion: Tablet of sambiloto EA-96 fraction (AS201-01) decreased TLR2 expession better than with DHP tablet.
format Article
PeerReviewed
author Masyitah Hamidah, -
Aty Widyawaruyanti, -
Widjiati, -
Budi Prasetyo, Budi
author_facet Masyitah Hamidah, -
Aty Widyawaruyanti, -
Widjiati, -
Budi Prasetyo, Budi
author_sort Masyitah Hamidah, -
title Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model
title_short Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model
title_full Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model
title_fullStr Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model
title_full_unstemmed Sambiloto (AS201) is better than standart antimalarial drug (DHP) in reducing Toll-Like Receptor 2(TLR2) on placenta malaria model
title_sort sambiloto (as201) is better than standart antimalarial drug (dhp) in reducing toll-like receptor 2(tlr2) on placenta malaria model
publisher Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Airlangga
url https://repository.unair.ac.id/127227/1/1.%20Sambiloto%20AS%2020I-0I.pdf
https://repository.unair.ac.id/127227/2/1.pdf
https://repository.unair.ac.id/127227/3/1.%20Sambiloto%20AS%2020I-0I.pdf
https://repository.unair.ac.id/127227/
https://e-journal.unair.ac.id/MOG/article/view/9449
https://doi.org/10.20473/mog.V26I22018.74-82
_version_ 1769840080193585152